Michelle assumed the role of CEO at PanKind, the Australian Pancreatic Cancer Foundation, in August 2020. With extensive experience in medical research funding, foreign investment attraction, digital health, and international clinical trials, she has been involved in numerous global transformative initiatives. Among her achievements, Michelle led the Australian arm of an initiative to establish a global digital patient community aimed at expediting clinical research across all diseases. Additionally, she has played integral roles in international collaborative endeavours focused on accelerating research for rare cancers. Dedicated to fostering enduring alignment around shared objectives to address systemic health issues at their core, Michelle played a pivotal part in reshaping Australia's brain cancer research funding landscape. Beginning as Head of Research Strategy, she oversaw research allocations, before advancing to the CEO role, where her team successfully secured a $100 million fund for brain cancer through strategic partnerships. Michelle's professional trajectory spans diverse sectors, including banking, telecommunications, clinical research, and government spheres. She holds a Bachelor of Advanced Science (Biochemistry and Psychology) and a Masters of Public Health, both earned from the University of Sydney.